Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications expression p glycoprotein human peripheral blood mononuclear cells transformed cell
… Real-World Evidence Fills Gaps in Blood Cancer Research Share on: February 12, 2022 Most of … with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) comes from clinical trials. However, … Mar 18;10:2690-702. doi: 10.1002/cam4.3855. Goyal RK, Jain P, Nagar SP, Le H, Kabadi SM, Davis K, Kaye JA, Du XL, Wang …
… International Symposium on Merkel Cell Carcinoma (ISMCC 2022) Share on: Monday, April 25, 2022 … will be presented at the International Symposium on Merkel Cell Carcinoma (ISMCC 2022). Bhatia S, Nghiem P, Veeranki SP, Vanegas A , Lachance K, Tachiki L, Chiu K, …
… New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor …
… Clinical and Economic Impact of Blood-Based Biomarkers for Mild Traumatic Brain Injury Share … biomarker tests that measure brain-specific proteins in human blood after an injury that may help to rule out intracranial …
… 2022 Peripheral Nerve Society (PNS) Annual Meeting Share on: … Solutions researchers is being presented at the 2022 Peripheral Nerve Society (PNS) Annual Meeting. Use of …
… Efficiency, Patient Access, and Costs Associated with Blood Platelet Processing Methods – New Research Share on: August 17, 2021 When a person donates blood platelets, those platelets become life-saving … treatments for a variety of conditions. The amount of blood platelet components (PCs) available at any given time …
… diseases including regenerative medicine, such as gene and cell therapies. Carla (DeMuro) Romano has extensive …
… patterns and outcomes in resectable early-stage non-small cell lung cancer (NSCLC): a global real-world study. Lin SH, …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… developing a market access strategy prior to your gene or cell therapy or tissue-engineered product obtaining … with our clients on projects to research a variety of cell and gene therapies. Our experience with these therapies includes several disease areas: Sickle cell disease Neuronal ceroid lipofuscinosis type 2 (CLN2) …